Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Islamic Azad University, Tehran Medical Branch, Tehran, Iran.
BMC Cardiovasc Disord. 2024 Nov 1;24(1):613. doi: 10.1186/s12872-024-04297-w.
This study aimed to identify the factors most strongly associated with an increased atherosclerotic cardiovascular disease (ASCVD) risk score in patients with type 2 diabetes (T2D).
This cross-sectional study included 4698 patients with T2D over an 11-year period (2010-2021). Patients were categorized into four groups based on their 10-year ASCVD risk score (< 5%, 5-7.5%, 7.5-20%, and > 20%). Multinominal regression analysis was used to evaluate the association between various modifiable and non-modifiable risk factors and the ASCVD risk score.
Of the patients, 35.9% had a 10-year ASCVD risk score below 5%, 12.6% had a score between 5% and 7.5%, 30.8% had a score between 7.5% and 20%, and 19.7% had a score above 20%. Higher ASCVD risk scores were significantly associated with elevated waist-to-hip ratio (WHR > 0.93), pulse pressure, uric acid, triglycerides, and decreased glomerular filtration rate (all p-values < 0.05). WHR demonstrated the strongest association with higher ASCVD risk scores (OR: 4.55, 95% CI: 2.94-7.03, p < 0.001) when comparing patients with ASCVD scores > 5% to those with scores < 5%.
WHR was independently associated with higher ASCVD risk scores in patients with T2D. Incorporating WHR, along with traditional risk factors, could improve ASCVD risk assessments in this population.
本研究旨在确定与 2 型糖尿病(T2D)患者动脉粥样硬化性心血管疾病(ASCVD)风险评分增加相关的最强因素。
这是一项横断面研究,纳入了 4698 例在 11 年内(2010-2021 年)患有 T2D 的患者。根据患者的 10 年 ASCVD 风险评分(<5%、5-7.5%、7.5-20%和>20%),将患者分为四组。使用多项回归分析评估各种可改变和不可改变的危险因素与 ASCVD 风险评分之间的关系。
在患者中,35.9%的 10 年 ASCVD 风险评分低于 5%,12.6%的评分在 5%至 7.5%之间,30.8%的评分在 7.5%至 20%之间,19.7%的评分高于 20%。较高的 ASCVD 风险评分与较高的腰围臀围比(WHR>0.93)、脉压、尿酸、甘油三酯和肾小球滤过率降低显著相关(所有 p 值均<0.05)。当比较 ASCVD 评分>5%的患者与评分<5%的患者时,WHR 与更高的 ASCVD 风险评分的关联最强(OR:4.55,95%CI:2.94-7.03,p<0.001)。
WHR 与 T2D 患者的 ASCVD 风险评分升高独立相关。在该人群中,将 WHR 与传统危险因素相结合,可以改善 ASCVD 风险评估。